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Abstract
Background: The Human cervical cancer oncogene (HCCR-1) has been isolated as a human
oncoprotein, and has shown strong tumorigenic features. Its potential role in tumorigenesis may
result from a negative regulation of the p53 tumor suppressor gene.
Results: To investigate the biological function of HCCR-1 in the cell, we predicted biological
features using bioinformatic tools, and have identified a LETM1 homologous domain at position 75
to 346 of HCCR-1. This domain contains proteins identified from diverse species predicted to be
mitochondrial proteins. Fluorescence microscopy and fractionation experiments showed that
HCCR-1 is located in mitochondria in the COS-7, MCF-7 and HEK/293 cell lines, and
subcompartamentally at the outer membrane in the HEK/293 cell line. The topological structure
was revealed as the NH2-terminus of HCCR-1 oriented toward the cytoplasm. We also observed
that the D1-2 region, at position 1 to 110 of HCCR-1, was required and sufficient for
posttranslational mitochondrial import. The function of HCCR-1 on mitochondrial membrane is to
retard the intrinsic apoptosis induced by UVC and staurosporine, respectively.
Conclusion: Our experiments show the biological features of HCCR-1 in the cell, and suggest that
uncontrolled expression of HCCR-1 may cause mitochondrial dysfunction that can result in
resisting the UVC or staurosporine-induced apoptosis and progressing in the tumor formation.
Background
Mitochondria are responsible for a number of metabolic
tasks in eukaryotic cells. Their primary function is to gen-
erate energy through oxidative phosphorylation in
organelles. Mitochondria also play an important role in
other biological activities such as programmed cell death
[1], calcium signaling and generation of detoxification of
reactive oxygen species [2].
Mitochondria consist of four subcompartments – an outer
membrane, an inner membrane, an inter-membrane
space and matrix. The chaperone proteins, and the
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translocase components, help mitochondrial transport
into the subcompartments through their membranes [3].
During the cytoplasmic translation of mitochondrial pro-
teins, they are recognized by chaperone proteins which
interfere with the folding of the protein. A positively
charged signal sequence, on the mitochondrial protein,
then binds to the translocase components called translo-
case of the outer mitochondrial membrane (TOM)
located on the outer mitochondrial membrane [4,5], the
protein is moved into the TOM complex. Translocase of
the inner mitochondrial membrane (TIM) [6,7], is an
inner membrane protein complex that forms a pore, and
acts to pull the mitochondrial protein through the pore.
On the inside of the pore, different chaperone proteins
recognize the mitochondrial protein and fold it into a
functional form. The signal sequence is removed by a
mitochondrial signal peptidase as the mitochondrial
protein enters the matrix.
The leucine zipper-, EF-hand-containing transmembrane
protein 1 (LETM1) is one of the mitochondrial proteins
that is posttranslationally imported into the mitochon-
drial inner membrane [8]. This gene has been identified
from the Wolf-Hirschhorn syndrome (WHS) [9] which is
characterized by multiple congenital anomalies, severe
pre- and post-natal growth retardation and mental retar-
dation [10,11]. In almost all patients with WHS, LETM1 is
part of a deletion found at the chromosome 4 location
[9]. Its role in WHS may be based on mitochondrial K+
homeostasis [12].
The human cervical cancer oncogene (HCCR) has been
isolated and identified as a human oncoprotein [13]; it
has revealed strong tumorigenic features in experiments
on nude mice [13]. Its role in tumorigenesis may be neg-
ative regulation of the p53 tumor suppressor gene [13].
HCCR-transgenic mice have been shown to develop
breast cancers and metastasis [14]. In order to investigate
the functional role of HCCR-1, we predicted the biologi-
cal features using bioinformatic tools. In addition, we
identified the subcellular location and the targeting signal
of HCCR-1.
Results and Discussion
HCCR-1 has a LETM1 homologous domain, and is 
predicted to be a mitochondrial protein
Since HCCR-1 has been shown to have tumorigenic fea-
tures previously [13,14] we focused on the biological
functions of HCCR-1 in the cell. In order to determine the
functional domain of HCCR-1 at the molecular level,
Pfam version 18.0 was used to analyze its amino acid
sequences and identified with the LETM1 homologous
domain at amino acids 75 to 346 of HCCR-1 (Fig 1A).
Sequence alignment between the domain from HCCR-1
and from the LETM1 protein using CLUSTALW [15]
showed a 57.61% sequence similarity. From the analysis
using Pfam, we also identified several LETM1 domain-
containing proteins, in various eukaryotic species, from
human through fungi as well as plant (Fig 1B); these find-
ings suggest that the domain has widespread application
in organisms and is well conserved during evolution, and
that the LETM1 domain may have an important biological
function in the normal life cycle.
Since some of the LETM1 domain-containing proteins
have been identified as mitochondrial proteins [8], we
analyzed the subcellular localization of the LETM1
domain-containing proteins using the TargetP version 1.1
[16] and Predotar version 1.03 [17]. As shown at Table 1,
almost all proteins were predicted to be mitochondrial
proteins with a high score (Table 1). It strongly suggests
that LETM1 domain may play an important role in mito-
chondria.
HCCR-1 is expressed on the mitochondrial outer 
membrane
In order to examine the subcellular localization of HCCR-
1, cDNA was subcloned into a pEGFP-N1 vector. COS-7
and MCF-7 cells were cultured on a pre-coated coverslip
and transiently transfected with the pEGFP-N1 vector (Fig
2A, GFP) or the vector carrying the human HCCR-1 cDNA
(Fig 2A, HCCR-1/GFP). The cells were then further incu-
bated for 24–28 h and their mitochondria were stained
with MitoTracker for 15 min at 37°C. The cells were fixed,
mounted, and analyzed by confocal microscopy (Fig 2A,
top through forth panels). We also used the HEK293 cell
line which stably expresses the V5 tagged HCCR-1 (Fig 2A,
HEK293/HCCR-1-V5). The cultured cells on the pre-
coated coverslip were stained with MitoTracker, fixed with
100% methanol for 1 min at -20°C. Mouse anti-V5 anti-
body and goat anti-mouse IgG antibody conjugated with
horseradish peroxidase (HRP) were applied to the cells for
1 h at room temperature. The stained cells were mounted
and analyzed by confocal microscopy (Fig 2A, Bottom
panel). The HCCR-1 fluorescence images revealed a stain-
ing pattern resembling mitochondria in all tested cell
lines (Fig 2A, HCCR-1/GFP and HCCR-1-V5). The visual-
ized mitochondria, as a result of incubation with a mito-
chondria-specific dye (Fig 2A, MitoTracker), were overlaid
with HCCR-1/GFP or HCCR-1-V5 (Fig 2A, merge) while
the vector alone (Fig 2A, GFP) did not merge with the
mitochondria; these findings suggest that HCCR-1 is
localized at the mitochondria.
Sequence analysis of the HCCR-1 protein, using the
Hopp-Woods method of calculating hydrophilicity and
TMHMM Server Version 2.0 [18], revealed the presence of
two hydrophobic segments, one extending from 139 to
161 residues which was predicted a transmembrane
domain (TM) and the other extending from position 81 toBMC Cell Biology 2007, 8:50 http://www.biomedcentral.com/1471-2121/8/50
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Alignments of HCCR-1 with its homologs Figure 1
Alignments of HCCR-1 with its homologs. (A) Alignment of HCCR-1 with Human LETM1 protein (gi18204589 ref 
AAH21208). Identities are highlighted in black and conserved substitutions by gray. (B) Schematic alignment shows the LETM1 
domain structure. Analysis using Pfam revealed sequence similarity with the LETM1 domains. Scale is lengths proportional to 
their molecular masses. The locations of putative LETM domains are indicated by blank boxes. Homo sapiens gi18204589 ref 
AAH21208; Homo sapiens (HCCR-1) gi13624098 ref AAK34885; Mus musculus gi33416955 ref AAH55685; Drosophila mela-
nogaster gi21626751 ref AAM68317; Drosophila melanogaster gi1749774 ref CAA71125; Molgula oculata, gi308969 ref 
AAC37181; Caenorhabditis elegans, gi17561658 ref NP_506382; Saccharomyces cerevisiae, gi6324546 ref NP_014615; Saccha-
romyces cerevisiae, gi1762146 ref AAB70096; Ashbya gossypii gi44980464 ref AAS50397; Ashbya gossypii, gi44980448 ref 
AAS50381; Neurospora crassa gi32420419 ref XP_330653; Arabidopsis thaliana, gi42562974 ref NP_176732.BMC Cell Biology 2007, 8:50 http://www.biomedcentral.com/1471-2121/8/50
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Table 1: Prediction of mitochondrial targeting of HCCR-1 and LETM1 domain-containing proteins.
TargetP Predotar
Score RC Score
Human AAH21208 0.882 2 0.74
AAK34885 0.898 1 0.39
Mouse AAH55685 0.442 4 0.04
Fly AAM68317 0.932 2 0.04
CAA71125 0.861 2 0.72
Squirt AAC37181 0.670 4 0.68
Worm NP_506382 0.943 2 0.84
Fungi NP_014615 0.924 1 0.75
AAB70096 0.822 3 0.78
AAS50397 0.934 1 0.85
AAS50381 0.920 1 0.81
XP_330653 0.798 2 0.10
Plant NP_176732 0.634 4 0.09
Mitochondrial targeting sequences were detected by TargetP version 1.1 [16] and Predotar version 1.03 [17]. TargetP calculates relative for 
mitochondrial localization. The reliability classes (RC) of TargetP provide a score from 1 to 5, where 1 indicates the strongest prediction. Predotar 
provides a probability estimate as to whether the sequence contains a mitochondrial targeting sequence. Proteins with scores above 0.5 are very 
probably targeted to the mitochondria.
98 amino acids which may be involved in anchoring to a
membranous component. Therefore, HCCR-1 is
predicted to be an integral membrane protein.
To examine whether HCCR-1 is a mitochondrial mem-
brane protein, the HEK293/HCCR-1-V5 cell lines were
studied for subcelllular fractionation experiments.
Nuclear (Fig 2B, lane1), post-mitochondrial supernatant
(Fig 2B, lane2), and mitochondrial (Fig 2B, lane3) frac-
tions were separated by differential centrifugation. The
isolated mitochondria were solubilized by treatment with
alkaline sodium carbonate [19] and ultra-centrifuged to
separate the soluble proteins (Fig 2B, lane 5) from the
insoluble integral membrane proteins (Fig 2B, lane 4).
Each of the fractionated proteins were displayed by SDS-
PAGE and analyzed by immunoblotting using antibodies
to the V5 epitope (Fig 2B, top panel), voltage dependant
anion channel 1 (VDAC-1) which is expressed on the
mitochondrial membrane [20] (Fig 2B, middle panel)
and superoxide dismutase-2 (SOD-2) on the mitochon-
drial matrix [21] (Fig 2B, bottom panel). The HCCR-1
protein was found in the mitochondrial fraction (Fig 2B,
lane3) which is consistent with the previous result shown
in figure 2A. Treatment with alkaline sodium carbonate
did not solubilize the mitochondrial integral membrane
protein VDAC-1 (Fig 2B, middle panel, lane 4), but did
disrupt the mitochondrial membrane as a result of expos-
ing the matrix protein SOD-2 (Fig 2B, bottom panel, lane
5). HCCR-1 protein also remained in the pellet fraction
(Fig 2B, top panel, lane 4); these findings suggest that
HCCR-1 is exclusively localized in the mitochondrial
membrane.
Since HCCR-1 was localized to the mitochondrial mem-
brane, we evaluated the topological structure of HCCR-1.
Bioinformatic analyses using the TMHMM Server Version
2.0 [18], showed that the NH2-terminus of HCCR-1 is
exposed to the cytoplasm, and also predicted that HCCR-
1 is a type II integral membrane protein.
To examine the HCCR-1 topology, the intact mitochon-
dria were isolated from HEK293/HCCR-V5 cell lines and
incubated with and without proteinase K or proteinase K
plus Triton X-100. Each treatment was subjected to SDS-
PAGE and visualized by immunoblotting using antibod-
ies to the V5 epitope (Fig 2C, top panel), TOM40 which
expresses on the outer mitochondrial membrane [4,5]
(Fig 2C, second panel), TIM23 on the inner mitochon-
drial membrane [6,7] (Fig 2C, third panel), and SOD-2 on
the mitochondrial matrix (Fig 2C, bottom panel). TIM23
and SOD-2 proteins were protease resistant in the mito-
chondria, which indicate that these proteins were not
exposed to the surface. By contrast, Tom40, an outer
membrane protein protruding to the surface, was sensitive
to proteinase K and weakly detected by its polyclonal anti-
body (Fig 2C, lane 2). Interestingly, the immunoblot anal-
ysis, using anti-V5 monoclonal antibody, detected two
sized proteins – a full sized HCCR-1-V5 (about 39 kDa)
and a little smaller sized protein (about 32 kDa); this indi-
cates that the NH2-terminus of HCCR-1 was partially
degraded by the proteinase K, while the COOH-terminus
of HCCR-1, containing V5 epitope, was protected from
the protease activity in the intact mitochondria. This sug-
gests that HCCR-1 is located on the outer mitochondrial
membrane (Fig 2C). This result also suggests that theBMC Cell Biology 2007, 8:50 http://www.biomedcentral.com/1471-2121/8/50
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HCCR-1 is localized on the mitochondria outer membrane Figure 2
HCCR-1 is localized on the mitochondria outer membrane. (A) COS-7 (top and second panels), MCF-7 (third and 
forth panels) and HEK293/HCCR-1-V5 (bottom panel) cells were cultured on the pre-coated coverslip for overnight. COS-7 
and MCF-7 cells were transiently transfected with the pEGFP-N1 vector (GFP) or the vector carrying the human HCCR-1 
gene tagged with GFP at its COOH-terminus (HCCR-1/GFP). The cells were incubated with MitoTracker (Red), fixed with 4% 
paraformaldyhyde. HEK293/HCCR-1-V5 cells were stained with MitoTracker (Red) and fixed with 100% methanol for 1 min at 
-20°C. Mouse anti-V5 antibody (1:300 dilution) and goat anti-mouse IgG conjugated with HRP (5 μg/ml) were applied to the 
cells for 1 h at room temperature (HCCR-1-V5). The cells were mounted and examined using a confocal microscope. (B) 
HCCR-1 is expressed at the mitochondrial membrane in the HEK293 cell line. Subcellular fraction of HEK293/HCCR-1-V5 cell 
line. HEK293/HCCR-1-V5 cells were fractionated into the nuclei (lane 1), post-mitochondria (lane 2), and mitochondria (lane3) 
fractions by differential centrifugation. Isolated mitochondria were treated with 0.1 M Na2CO3 and fractionated by centrifuga-
tion at 100,000 g into pellets (lane 4) and supernatant (lane 5). Proteins were analyzed by immunoblotting using antibodies to 
the V5 epitope (top panel), the mitochondrial membrane protein VDAC-1 (middle panel) and the mitochondrial matrix protein 
SOD-2 (bottom panel). (C) HCCR-1 topology on the mitochondrial outer membrane. Intact mitochondria were incubated for 
30 min at room temperature without (lane 1) and with 50 μg/ml proteinase K (lane 2) or with 50 μg/ml proteinase K plus 1% 
Triton X-100 (lane 3). Each sample was precipitated with TCA and separated by SDS-PAGE and analyzed by immunoblotting 
with antibodies to V5 (top panel), to the outer membrane protein TOM40 (second panel) and to the inner membrane protein 
TIM23 (third panel), and to the matrix protein SOD-2 (bottom panel). (D) Schematic diagram shows the HCCR-1 topology at 
the outer mitochondrial membrane.BMC Cell Biology 2007, 8:50 http://www.biomedcentral.com/1471-2121/8/50
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topological structure of HCCR-1 is indeed consistent with
the bioinformatic prediction as shown in figure 2D. Upon
disintegration of the membrane proteins by treatment
with Triton X-100, all proteins were digested by protein-
ase K, showing that none of them was intrinsically pro-
tease-resistant (Fig 2C, lane 3).
Mitochondrial targeting sequences are in the NH2-
terminus of HCCR-1
The targeting signal, on mitochondrial proteins, often
exists on their DNA fragments coding for the amino termi-
nal region of the protein [22-24] and does not have a
conserved sequence, but rather share a common physical
property. This feature is the ability to form an amphip-
athic α-helix, one in which positively charged amino acids
are localized to one surface of the helix [25-27]. This sig-
nal sequence is recognized by the receptors on the mito-
chondrial outer membrane and imported into
mitochondria. We have shown that HCCR-1 is also a
mitochondrial protein. This protein may be posttransla-
tionally transported to mitochondria and then imported
into mitochondria by recognition of the signal sequence.
To determine the mitochondrial targeting signal of
HCCR-1, three different sizes of the NH2-teminal DNA
fragments were subcloned into a pEGFP-N1 expression
vector (Fig 3A). Each of the constructs was transfected into
COS-7 cells and the mitochondria were stained and exam-
ined by confocal microscopy (Fig 3B). HCCR D1-1, which
contains NH2-terminal segments at positions 1 to 78 resi-
dues, was localized diffusely in the cytoplasm and nuclei
(Fig 3B, third panel). This distribution is more like that of
GFP alone (Fig 3B, top panel). By contrast, the deletion
mutants, HCCR D1-2 and D1-3, which contained at posi-
tion 1 to 110 and 1 to 173 respectively, exhibited a typical
mitochondrial pattern, and were overlaid with their mito-
chondrial staining (Fig 3B, forth and bottom panels); this
suggests that the D1-2 region which partially contains
LETM1 domain, contains the mitochondrial targeting
sequence and D1-1 region alone cannot reach the mito-
chondria. We also tested these constructs in NIH3T3 and
MCF-7 cells, and obtained the same results as in COS-7
cells (Data not shown).
The D1-2 region of HCCR-1 is required for its 
mitochondrial targeting
The 2nd structural analysis of the D1-2 region, using GOR
IV secondary structure prediction method [28], identified
an α-helical domain from 92 to 110 which belongs to
LETM1 domain of HCCR-1 and this domain represented
an amphipathic α-helical feature which often plays a role
in the mitochondrial targeting signal [25-27]. To further
characterize the HCCR-1 targeting signal, the positions 1
to 56 were deleted from HCCR D1-1, -2 and -3 constructs
(Fig 4A). Each construct was transfected into COS-7 cells
and examined by confocal microscopy (Fig 4B). The
HCCR D2-1 construct exhibited a diffuse pattern in the
cytoplasm and nuclei resembling that of GFP alone in
COS-7 cells (Fig 4B, top panel). The HCCR D2-2 construct
contains an amphipathic α-helical domain. This construct
also showed a diffuse distribution in cytoplasm and
nuclei (Fig 4B, middle panel), which is different from the
pattern of HCCR D1-2, and suggests that the NH2-termi-
nal region from 1 to 56 is also required for mitochondrial
targeting. However, some of the D2-2 mutant was trans-
ported to mitochondria (Fig 4B, middle panel), which
suggests that this region between 57 and 110 as well as the
region from 1 to 56 is involved in the mitochondrial tar-
geting. When the HCCR D2-3 construct was expressed in
COS-7 cells, it was not detected in nuclei but in cytoplasm
and other organelles (Fig 4B, bottom panel). The D2-3
mutant contains the transmembrane domain which is
moderately hydrophobic [18]. This may result in absence
in nuclei and reaching into the mitochondria or other
organelles [29,30].
Therefore, the mitochondrial localization of HCCR-1
requires its D1-2 region, which partially belongs to the
LETM1 domain of HCCR-1. By contrast, D1-1 which con-
tains NH2-terminus of HCCR-1 and D2-2 which belongs
the LETM1 domain of HCCR-1, were prevented from
localizing to mitochondria. This suggests that the D1-1
region may be co-related with the D2-2 region for mito-
chondrial targeting.
HCCR D1-2 mutant was exclusively localized at the 
mitochondria
In order to confirm the previous results obtained by con-
focal microscopy experiments, COS-7 cells expressing
HCCR D1-2 and D2-2 were subjected to subcellular frac-
tionation. Nuclear (Fig 5A and 5B, lane 1), post-mito-
chondrial supernatant (Fig 5A and 5B, lane2), and
mitochondrial (Fig 5A and 5B, lane3) fractions were sep-
arated by differential centrifugation, and analyzed by
Western blotting using antibodies to the GFP (Fig 5A and
5B, top panel) and the mitochondrial membrane protein
VDAC-1 (Fig 5A and 5B, bottom panel). As expected, the
deleted mutant D1-2 was exclusively localized to the
mitochondrial fraction (Fig 5A), while the D2-2 exhibited
all fractions (Fig 5B). These data confirmed that the D1-2
domain is essential for the mitochondrial targeting of
HCCR-1.
At the figure 4B and 5B, most of D2-2 and D2-3 mutants
are located on mitochondria although some of them are
failed to reach to mitochondria. This suggests that HCCR-
1 cytosolic form such as HCCR-2 which is deleted at
position 1 to 56 amino acids, may exist. This cytosolic
form could act as a negative regulator of p53 or could not.
However, we propose that this form may not affect the
HCCR function because it may also mainly localize at
mitochondria.BMC Cell Biology 2007, 8:50 http://www.biomedcentral.com/1471-2121/8/50
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NH2-terminus of HCCR-1 contains the mitochondrial targeting information Figure 3
NH2-terminus of HCCR-1 contains the mitochondrial targeting information. (A) Schematic structure of HCCR-1 
and its deleted mutants which were COOH-terminally linked by the GFP reporter gene. Grey boxes indicate the hydrophobic 
region. TM boxes indicate the locations of putative transmembrane domain. (B) Expression of wild-type or deleted mutants in 
COS-7 cells. COS-7 cells were transfected with the indicated constructs in the expression vectors. The cells were incubated 
with MitoTracker and fixed. Fluorescent images of GFP (green), MitoTracker (red) were taken using a confocal microscope. 
Merged fluorescent images of GFP and MitoTracker are shown. Other conditions are described in Materials and methods.BMC Cell Biology 2007, 8:50 http://www.biomedcentral.com/1471-2121/8/50
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Mitochondrial targeting of HCCR-1 requires the D1-2 region Figure 4
Mitochondrial targeting of HCCR-1 requires the D1-2 region. (A) Schematic structure of HCCR-1 deleted mutants 
which were COOH-terminally linked by the GFP reporter gene. Grey boxes indicate the hydrophobic region. TM boxes indi-
cate the locations of putative transmembrane domain. (B) Expression of deleted mutants in COS-7 cells. COS-7 cells were 
transfected with the indicated constructs in the expression vectors. Other conditions were same as in Figure 3B.BMC Cell Biology 2007, 8:50 http://www.biomedcentral.com/1471-2121/8/50
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Suppression of UVC- or staurosporine-induced apopotosis 
in HCCR-1 overexpressed cell
To verify the role of HCCR-1 on mitochondrial outer
membrane and p53 negative regulation role, we used the
HEK293 cell line which stably expresses the vector alone
(HEK293/Vector) and V5 tagged HCCR-1 (HEK293/
HCCR-1), respectively. The cells were stimulated with the
40 J/m2 of the short-wave length light (UVC) ray, 100 nM
staurosporine or 300 nM actinomycin D for trigging
apoptosis. After the stimulation, the cells were stained
with propidium iodide and analyzed by FACS. The cell
number of apoptotic sub G0/G1-phase in the HEK293/
HCCR-1 cells after treatment with UVC or staurosporine
was less increased in comparing with that in HEK293 and
HEK293/Vector cells, in respectively (Fig 6). The cell
number of apoptotic phase in the HEK293/HCCR-1 after
treatment with actinomycin D was not significantly
changed at all tested cell line (Fig 6). Our flow cytometric
data indicate that UVC or staurosporine induced-nuclear
apoptosis is retarded in HEK293/HCCR-1 cells, which
suggest that HCCR-1 induces HEK293 cells more resist-
ance to UVC-ray and staurosporine-triggered apoptosis,
but not in actinomycin D.
We have shown that overexpression of the cDNA encod-
ing HCCR-1 led to the detection of the protein in mito-
chondira compartment in COS-7, MCF-7 and HEK-293
cells (Fig 2A). However, the previous immunofluores-
cence study showed that HCCR was predominantly local-
ized in the plasma membrane and cytoplasm of
hepatocellular carcinoma [31]. Interestingly, our resent
HCCR D1-2 mutant was exclusively localized at the mito- chondria Figure 5
HCCR D1-2 mutant was exclusively localized at the 
mitochondria. COS-7 cells were transfected with HCCR 
D1-2 (A) and D2-2 (B) which were linked with GFP at its 
COOH-termini and then incubated for 2 days. The cells 
were fractionated into the nuclei (lane 1), post-mitochondria 
(lane 2), and mitochondria (lane3) fractions. Each 10 μg of 
proteins was separated by SDS-PAGE and analyzed by immu-
noblotting using antibodies to the GFP epitope (top panel), 
the mitochondrial protein VDAC-1 (bottom panel).
Suppression of UVC- and stauroeporine-induced apopotosis  in HCCR-1 overexpressed cell Figure 6
Suppression of UVC- and stauroeporine-induced apo-
potosis in HCCR-1 overexpressed cell. (A) HEK293, 
HEK293/Vector and HEK293/HCCR-1 cells were exposed to 
40 J/m2 of the short-wave length light (UVC) ray, 100 nM of 
staurosporine and 300 nM of actinomycin D, in respectively. 
The cells were than stained with propidium iodide and ana-
lyzed by FACS. The % of apoptotic cells from each analysis 
were presented on a bar graph.BMC Cell Biology 2007, 8:50 http://www.biomedcentral.com/1471-2121/8/50
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analysis of HCCR mRNA using reverse transcription-PCR
and sequencing has identified several HCCR isoforms
from various cancerous cell lines and tissues (data not
shown). The expression of these isoforms also depended
on the cell type and tissues, while some of the isoforms
were predicted to be different subcellular organelles. This
could be invoked, for example, to account for the genera-
tion of the other cellular compartment pool of HCCR.
HCCR-1 has been isolated and identified as a strong onco-
protein with tumorigenic features [13,14]. Interestingly,
this protein has been localized to the mitochondrial
membrane which has been deeply related to the intrinsic
apoptotic signal [1,32]. Here, we showed that the onco-
protein HCCR-1 represses mitochondrial dysfunction
caused by its uncontrolled expression. This may prevent
the apoptotic signal, block the senescence, and induce
cancer development. Therefore, the present data now
make it possible to investigate mitochondrial function
and mitochondria-mediated apoptosis in HCCR-1 over-
expressed cells.
Conclusion
We report that HCCR-1 is a LETM1 domain homologous
protein and is predicted to be a mitochondrial protein.
Fluorescence microscopy and fractionation experiments
showed that HCCR-1 localizes to the mitochondria in
COS-7, MCF-7 and HEK293 cell lines and subcomparta-
mentally at its outer membrane in HEK293 cell lines. Its
topology is revealed by the NH2-terminus of HCCR-1
which is oriented toward the cytoplasm. We also demon-
strated that the HCCR D1-2 domain (amino acids 1–110)
is required and sufficient for posttranslational mitochon-
drial import. Finally, the function of HCCR-1 on mito-
chondrial membrane suppresses the intrinsic apoptotic
signal which is induced by UVC and staurosporine, in
respectively.
Methods
Cell culture and Transfection
Human embryonic kidney (HEK) 293 (ATCC CRL-1573),
COS-7 (ATCC CRL-1651) and MCF-7 breast cancer
(ATCC HTB-22) cells were obtained from the American
Type Culture Collection (Manassas, VA). HEK293/HCCR-
1-V5 cell line [13] which stably expressed V5 tagged
HCCR-1 in HEK293 cells, was maintained in DMEM
(Gibco, Grand Island, NY) containing 200 μg/ml G418,
10% FBS (Hyclone, Logan, Ut) and 1% PenStrep (Gibco,
Grand Island, NY). COS-7 cell line was maintained in
RPMI (Gibco, Grand Island, NY) supplemented with 10%
FBS and 1% PenStrep. All cells were incubated at 37°C,
5% CO2.
DNA constructs and Transfection
HCCR-1, and its deletion mutants, were amplified using a
Peltier Thermal Cycler PTC-200 (MJ Research, MA) with
the primers DL1-F (5'-CCGCTCGAGCGGAT-
GGCGCTCTCCAGGGTGTG-3') and FU-R (5'-CGGGATC-
CCGCGCCTTGTCCCAAGGTAGT-3') for HCCR-1 full
open reading frame (ORF), the primers DL1-F and DL1-R
(5'-CGGGATCCCCTGACGACCCAAGAAACGAT-3') for
D1-1, the primers DL1-F and DL2-R (5'-CGGGATC-
CCCATATTTGTCTTTATTCTTC-3') for D1-2, the primers
DL1-F and DL3-R (5'-CGGGATCCCGGGGGTCCA-
GAAATGCCTGAT-3') for D1-3, the primers DL2-F (5'-
CCGCTCGAGCGGATGTCTTATGTGGTAACCAA-3') and
DL1-R for D2-1, the primers DL2-F and DL2-R for D2-2,
and the primers DL2-F and DL3-R for D2-3. The primers
used in these PCR reactions were synthesized from Gen-
oTech (GenoTech, Daejeon, Korea). Restriction enzyme
sites were underlined – single lines for XhoI and double
lines for BamHI. The PCR cycling parameters were as fol-
lows: initial denaturation at 94°C for 2 min; 30 cycles of
30 s at 94°C for denaturation, 30 s at 55°C for primer
annealing, and 1 min at 72°C for extension; and final
extension at 72°C for 10 min. After amplification, the
PCR products were resolved by an agarose gel electro-
phoresis and purified using Qiagen columns (Qiagen Inc,
Valencia, CA). The PCR products were subcloned into the
pEGFP-N1 vector (Promega, Madison, WI) at XhoI and
BamHI sites and sequenced.
For the DNA transfection, all the recombinant plasmids
were prepared using Qiagen columns (Qiagen Inc, Valen-
cia, CA) and DNA transfection was performed according
to the manufacturer's instructions using LipofectAMINE
2000 reagent (Invitrogen, Carlsbad, CA). Plasmid DNA
(0.5 μg) was transfected to COS-7 cells grown on a 6 well
dish and the cells were incubated for 24 -28 h before
analysis.
Isolation and subfractionation of Mitochondria
Subcellular fractionation of HEK293/HCCR-1-V5 and
COS-7 cells was carried out according to the mitochondria
isolation kit (PIERCE, Rockford, IL). Briefly, cells were
harvested by centrifuging at 850 g for 2 min and the pellet
was suspended with 800 μl of reagent A, and then incu-
bated exactly 2 min on ice. Next 10 μl of Reagent B was
added to the suspended solution and incubated for 5 min
on ice with vortexing at maximum speed every minute.
Then 800 μl of Reagent C was added to the solution and
inverted the tube several times to mix. The solution was
centrifuged at 700 g for 10 min at 4°C, and the pellet was
used for crude nucleic fraction. The supernatant was con-
tinuously centrifuged at 12,000 g for 15 min at 4°C and
transferred to a new tube for the post-mitochondrial
supernatant fraction. The pellet was washed with 500 μl ofBMC Cell Biology 2007, 8:50 http://www.biomedcentral.com/1471-2121/8/50
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Regent C, and used for isolation of the mitochondrial
fraction.
For the isolation of the mitochondrial membrane frac-
tion, the isolated mitochondria were resuspended in 200
μl of freshly prepared 100 mM sodium carbonate pH 11.5
and incubated on ice for 30 min, and centrifuged at
100,000 g for 30 min at 4°C. The supernatant was used as
a mitochondrial matrix fraction. The pellet was resus-
pended with the same volume (200 μl) of 1X SDS loading
buffer and used as a mitochondrial membrane fraction.
Analysis of Topology
Intact mitochondria were isolated from cultured HEK293/
HCCR-1-V5 cells and diluted with MSB buffer (150 mM
Potassium acetate, 5 mM Magnesium acetate, 50 mM
HEPES pH 7.6, 200 mM Sucrose, 1 mM DTT) and treated
with or without 50 μg/ml of proteinase K or proteinase K
plus 1% Triton X-100 at room temperature for 30 min.
Stop proteolysis was performed by adding 15% (w/v)
trichloroacetic acid (TCA, Sigma-Aldrich Corporation,
MO) and incubating for 15 min on ice. TCA pellets were
collected by microcentrifuging for 5 min at 8,000 g, at
room temperature. The supernatants were carefully
removed and the pellets were suspended in 30 μl of 1X
SDS sample buffer by vortex mixing and subjected to
Western blot analysis.
Western blot analysis
Each fraction was quantified with the BCA Protein Assay
Reagent kit (PIERCE, Rockford, IL). Samples in 1X SDS
sample buffer were subjected to electrophoresis in a SDS-
PAGE and transferred to nitrocellulose by standard proce-
dures. Membranes were blocked with 5% nonfat milk
and 0.05% Tween 20 in TBS (Tris-buffered saline, pH8.0)
for 1 h at room temperature. After washing with 0.05%
Tween 20 in TBS, the membranes were incubated with
primary antibodies, anti-V5 (Invitrogen, Carlsbad, CA),
anti-GFP (Santa Cruz Biotechnology, Santa Cruz, CA),
anti-TOM40 (Santa Cruz Biotechnology, Santa Cruz, CA),
anti-TIM23 (Santa Cruz Biotechnology, Santa Cruz,
CA), anti-SOD-2 (Santa Cruz Biotechnology, Santa
Cruz, CA), or anti-VDAC1 (Santa Cruz Biotechnology,
Santa Cruz, CA) antibodies. After washing with 0.05%
Tween 20 in TBS, immunoblots were incubated with
horseradish-peroxidase conjugated rabbit anti-mouse IgG
(Santa Cruz Biotechnology, Santa Cruz, CA) or goat anti-
rabbit IgG (KPL, Gaithersburg, MD), and proteins were
visualized using enhanced chemiluminescence according
to the manufacturer's instructions (PIERCE, Rockford, IL).
Fluorescence Microscopy
Coverslips were washed with HCl, three times with dis-
tilled water and twice with 100% Ethanol. Dried cover-
slips were then coated with 5 μg/ml Poly-L-Lysine (Sigma-
Aldrich Corporation, MO) for overnight at 37°C. COS-7
and HEK293/HCCR-1-V5 cells were seeded onto pre-
coated coverslips in 6 well plates. Then following one day
incubation, the cells were transiently transfected using
LipofectAMINE 2000 (Invitrogen, Carlsbad, CA). After
24–28 h further incubation, 100 nM MitoTracker (Molec-
ular Probes, Eugene, OR) was added to the medium and
incubated for 15 min at the same culture condition and
washed three times with 2 ml PBS before fixation. The
cells on the coverslips were then fixed with 4% parafor-
maldyhyde containing 4% sucrose at 4°C for 10 min. To
stain V5 tagged HCCR-1, HEK293/HCCR-1-V5 cells were
fixed with 100% methanol at -20°C for 1 min and washed
three times with PBS and incubated with mouse anti-V5
antibody (Invitrogen, Carlsbad, CA) at a dilution of 1:300
for 1 h at room temperature. They were washed with PBS,
Alexa Fluor 488 goat anti-mouse IgG antibody (Molecular
Probes, Eugene, OR) at a dilution of 5 μg/ml was applied
for 1 h at room temperature. The cells were washed three
times with PBS and mounted using ProLong Gold Anti-
fade Reagents (Molecular Probes, Eugene, OR). Fluores-
cent images were analyzed and taken using a Bio-Rad
MRC-1024MP laser scanning confocal microscope (Bio-
Rad, Hercules, CA).
Flow cytometric analysis
The cells were stimulated with the 40 J/m2 of the short-
wave length light (UVC) ray and incubated then for 2
days, or with 100 nM staurosporine and 300 nM actino-
mycin D for overnight, in respectively. After the stimula-
tion, cells were washed two times with ice-cold PBS and
stored at -20°C with 5 ml of 70% Ethanol for a day. For
the Propidium iodide staining, cells were resuspended
and collected by centrifugation at 4°C and washed two
times with PBS and then resuspended with 0.5 ml of PBS.
10 μl of RNase (100 μg/ml) were added and the cells were
incubated at 37°C for 20 min. After removing RNAs, 1 μl
of Propidum iode (50 μg/ml) were added and incubated
at 37°C for 10 min for staining. And then analyzed on a
BRYTE HS flow cytometer (Bio-rad, Herts, England).
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